Follow Slashdot stories on Twitter

 



Forgot your password?
typodupeerror
Slashdot Deals: Prep for the CompTIA A+ certification exam. Save 95% on the CompTIA IT Certification Bundle ×
Medicine

Startup Tests Drugs Aimed at Autism 171

An anonymous reader sends in this link from Technology Review about a startup company testing drugs that may help those with autism-spectrum disorders — even adults. "Seaside Therapeutics, a startup based in Cambridge, MA, is testing two compounds for the treatment of fragile X syndrome, a rare, inherited form of intellectual disability linked to autism. The treatments have emerged from molecular studies of animal models that mirror the genetic mutations seen in humans. Researchers hope that the drugs, which are designed to correct abnormalities at the connections between neurons, will ultimately prove effective in other forms of autism spectrum disorders. ... The company is funded almost entirely by an undisclosed family investment of $60 million, with $6 million from the National Institutes of Health. [A spokesman] says that Seaside has enough funding to take its compounds through clinical testing and approval."
This discussion has been archived. No new comments can be posted.

Startup Tests Drugs Aimed at Autism

Comments Filter:

Related Links Top of the: day, week, month.

You might have mail.

Working...